Triple arthrodesis surgery is a procedure that has been around since the 1920s and is used to treat patients with severe pain due to arthritis and other joint problems. In recent years, this type of surgery has become increasingly popular among medical professionals as an effective way to reduce pain and improve mobility. We’ll also discuss how it differs from other ankle fusion procedures, as well as what to expect during the recovery process.
Arthrodesis is a surgical procedure that involves fusing three joints in the foot: the talonavicular, calcaneocuboid, and subtalar joints. The goal of this surgery is to relieve pain and improve function in the foot. Triple arthrodesis is typically reserved for patients who have failed to respond to non-surgical treatments, such as icing, anti-inflammatory medications, immobilization, and physical therapy.
This surgery is performed by making an incision in the front or back of the foot. The surgeon will then clean out the affected joints and insert metal implants to fuse them together. In some cases, a bone graft may be used to help promote healing. The incision will be closed with sutures or staples and the foot will be placed in a plaster cast or splint. Recovery from triple arthrodesis surgery takes several weeks. During this time, it is important to keep weight off of the foot as much as possible. Physical therapy may be recommended to help regain range of motion and strength in the foot. Most patients are able to return to their normal activities within three to six months.
– Severe pain in the foot that does not respond to conservative treatment, such as shoe inserts, orthotics, or physical therapy.
– Deformity of the foot that is causing difficulty with walking or standing.
– arthritis in three joints of the foot: the ankle joint, the subtalar joint, and the midtarsal joint.
– a fracture or dislocation in the bones of the foot that has not healed properly.
There are a few contra-indications to consider before performing triple arthrodesis surgery which include: active infection, Charcot foot, severe hallux valgus deformity, and patients who are non-compliant with post-operative management. Additionally, this procedure should be performed with caution in patients who have diabetes or any other condition that may cause poor healing.
After the patient has been given a general anaesthetic, the surgeon will make an incision in the front of the foot, cutting through the skin and soft tissue. They will then cut through the bone, making an opening in the joint.
The surgeon will then insert metal plates and screws into the bones to hold them in place. Once this is done, they will close up the incision with stitches or staples. The surgery usually takes around two hours to complete. The patient will be required to stay in hospital for a few days afterwards so that their progress can be monitored.
This usually includes a period of rest and elevation of the foot, as well as ice and over-the-counter pain medication to help with discomfort. Depending on the severity of the surgery, patients may also need to use crutches or a wheelchair for a period of time.
Most patients will start to feel better within a few weeks, but it can take up to three months for all swelling and bruising to subside. Physical therapy may be recommended to help with range of motion and strength.
-Infection
-Bleeding
-Nerve damage
-Arterial injury
-Stiffness
-Joint instability
-Implant failure or looseness
-Pain
The goal of this guide was to provide medical professionals with a comprehensive understanding of triple arthrodesis surgery. We have discussed the goals, benefits, and risks associated with the procedure as well as patient selection criteria and post-operative care. In addition, we provided an overview of relevant anatomy, indications for surgical intervention and complications that may arise during or after the operation.
1.
Q&A: When will individuals be able to receive customized cancer vaccines?
2.
Canadian Group Calls for Earlier Colorectal Cancer Screening
3.
Children living near oil and gas wells face higher risk of rare leukemia, studies show
4.
Researchers achieve a significant milestone in the management of anemia in chronic lymphocytic leukemia.
5.
Talquetamab Combos Show Survival Benefit in r/r Myeloma
1.
Liquid Biopsy: A Revolutionary Tool for Early Detection and Monitoring of Colorectal Cancer
2.
Clinical Pharmacology of Megakaryocyte Maturation-Targeted Therapeutics
3.
The Benefits and Side Effects of Bortezomib in the Fight Against Cancer
4.
Personalized Tumor Ecological Landscapes in Oncology
5.
Unmasking the Subtle Symptoms of Colon Cancer
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
2.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part II
3.
Current Scenario of Cancer- Q&A Session to Close the Gap Part II
4.
Cost Burden/ Burden of Hospitalization For R/R ALL Patients
5.
Immunotherapy: A New Era in Cancer Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation